Understand the source comparison
Best Peptides to Improve Libido Naturally Ranked: Clinical Evidence Comparison
PT-141 (Bremelanotide) MC4R agonist. Direct hypothalamic arousal signaling 30–90 minutes subcutaneous Phase 3 RCT data (RECONNECT). FDA-approved for HSDD Nausea (40–60%), flushing (25–35%), transient hypotension (10%) Strongest clinical evidence for acute libi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- PT-141 (Bremelanotide)
- MC4R agonist. Direct hypothalamic arousal signaling
- 30–90 minutes subcutaneous
- Phase 3 RCT data (RECONNECT). FDA-approved for HSDD
- Nausea (40–60%), flushing (25–35%), transient hypotension (10%)
- Strongest clinical evidence for acute libido enhancement in both men and women; most reliable mechanism
- Melanotan II
- Broad melanocortin agonist (MC1R, MC3R, MC4R)
- 2–4 hours subcutaneous
- Phase 2 trials and observational data. Not FDA-approved
- Nausea (50–70%), skin darkening (cumulative), facial flushing (30–40%)
- Similar arousal mechanism to PT-141 but with additional tanning effect; less selective receptor binding
- Kisspeptin-10
- GPR54 agonist. Stimulates GnRH pulsatility and HPG axis
- Hours to days (indirect hormonal pathway)
- Academic research studies (Imperial College, Harvard). No commercial trials
- Minimal acute side effects; requires IV or subcutaneous administration
- Restores GnRH signaling but impractical dosing and delayed onset limit real-world application
- VIP (Vasoactive Intestinal Peptide)
- Peripheral vasodilator. Increases penile blood flow via cAMP
- 10–20 minutes intracavernosal
- Clinical trials for ED (Invicorp). Mechanical effect only
- Injection site pain, priapism risk with excessive dosing
- Addresses erectile mechanics but not sexual desire; not a libido peptide
- GHRP-6 / Ipamorelin
- Growth hormone secretagogue. Indirect metabolic and mood effects
- Days to weeks (downstream GH/IGF-1 effects)
- No controlled trials for libido as primary endpoint
- Increased appetite, water retention, potential insulin resistance
- No direct libido mechanism; benefits are secondary to improved recovery and metabolic health